TY - JOUR
T1 - Anti-influenza A virus characteristics of a fucoidan from sporophyll of Undaria pinnatifida in mice with normal and compromised immunity
AU - Hayashi, Kyoko
AU - Lee, Jung Bum
AU - Nakano, Takahisa
AU - Hayashi, Toshimitsu
N1 - Funding Information:
We thank Dr. Minoru Hashimoto for preparing the crude fucoidan sample. This study was supported in part by a University of Toyama Grant-in-Aid .
PY - 2013/4
Y1 - 2013/4
N2 - Undaria pinnatifida, an edible brown alga, contains fucoidan (FuC), a sulfated polysaccharide, that inhibited the in vitro replication of influenza A virus, and stimulated both innate and adaptive immune defense functions in virus-infected mice. In the present study, the effects of oral administration of FuC were evaluated on influenza virus infection in immunocompetent and immunocompromised mice, where the efficacy of FuC was demonstrated in reducing viral replication, decreasing weight loss and mortality, and prolonging survival. Oral FuC resulted in increased neutralizing antibody production in the mucosa and blood. In contrast, while suppressing virus yields in mice more markedly than FuC, oseltamivir significantly reduced the neutralizing antibody titers in both the mucosa and blood. In immunocompromised mice, drug-resistant viruses frequently recovered after oseltamivir treatment; no resistant viruses were isolated from FuC-treated mice. FuC could be a candidate for the development of new therapeutic options including its combination with neuraminidase inhibitors such as oseltamivir.
AB - Undaria pinnatifida, an edible brown alga, contains fucoidan (FuC), a sulfated polysaccharide, that inhibited the in vitro replication of influenza A virus, and stimulated both innate and adaptive immune defense functions in virus-infected mice. In the present study, the effects of oral administration of FuC were evaluated on influenza virus infection in immunocompetent and immunocompromised mice, where the efficacy of FuC was demonstrated in reducing viral replication, decreasing weight loss and mortality, and prolonging survival. Oral FuC resulted in increased neutralizing antibody production in the mucosa and blood. In contrast, while suppressing virus yields in mice more markedly than FuC, oseltamivir significantly reduced the neutralizing antibody titers in both the mucosa and blood. In immunocompromised mice, drug-resistant viruses frequently recovered after oseltamivir treatment; no resistant viruses were isolated from FuC-treated mice. FuC could be a candidate for the development of new therapeutic options including its combination with neuraminidase inhibitors such as oseltamivir.
KW - Drug resistance
KW - Immunocompromised animal
KW - Influenza
KW - Sulfated polysaccharide
UR - http://www.scopus.com/inward/record.url?scp=84876096207&partnerID=8YFLogxK
U2 - 10.1016/j.micinf.2012.12.004
DO - 10.1016/j.micinf.2012.12.004
M3 - 学術論文
C2 - 23376164
AN - SCOPUS:84876096207
SN - 1286-4579
VL - 15
SP - 302
EP - 309
JO - Microbes and Infection
JF - Microbes and Infection
IS - 4
ER -